MBK Partners Dismisses Allegations on Non-Disclosure Agreement by Korea Zinc
Reading Time: 2 minutes Seoul, South Korea: MBK Partners categorically dismisses the baseless allegations made by Korea Zinc regarding an alleged breach of a Non-Disclosure Agreement (NDA). Despite prior clarification that the MBK Partners Buyout Division, which is participating in the tender
MBK Partners and Young Poong Refute Korea Zinc’s Baseless Claims
Reading Time: 2 minutes Seoul, South Korea: MBK Partners has clarified its position on a matter involving Korea Zinc, stating that the company is making claims that are far from reality. The matter dates back to May 2022, when a person known to be close
Curtiss-Wright and Sintavia Deliver First Submarine Component Utilizing an Additively Manufactured Impeller to be Installed in a U.S. Navy Vessel
Reading Time: 3 minutes Cheswick, Pa., United States: Curtiss-Wright’s EMS Division today announced that it has delivered the first submarine component with an additively manufactured (AM) impeller that will be installed in a U.S. Navy vessel. Curtiss-Wright’s Engineered Pump Division (EPD) in
Zwipe publishes prospectus related to the rights issue
Reading Time: 5 minutes THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY
SyntheticMR AB (publ) appoints Vedran Beglerbegovic as Acting CEO for SyntheticMR
Reading Time: < 1 minute The board of SyntheticMR AB (publ) has today decided to appoint Vedran Beglerbegovic as Acting CEO with immediate effect, due to the current CEO, Ulrik Harrysson, being on sick leave indefinitely. Vedran Beglerbegovic, who currently holds the position of COO
The Impact of Technology on Modern Architecture
Reading Time: 4 minutes Technology has evolved immensely in recent years and is having an impact on many areas of our lives. With new technologies, we are seeing revolutionised ways in which we design, construct, and experience buildings. From the earliest days of computer-aided
Leqembi® approved in Mexico – BioArctic
Reading Time: 4 minutes Stockholm, Sweden, December 5, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved Leqembi (lecanemab) for the treatment of early Alzheimer’s disease (AD)[1].
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 04.12.2024
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 04.12.2024 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 04.12.2024 Date 04.12.2024 Exchange transaction Buy Share class ALEX Amount 69 Average price/share 8.5500 EUR Highest
Nordea Bank Abp: Repurchase of own shares on 04.12.2024
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares04.12.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 04.12.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average
OBSERVE MEDICAL ASA: Preliminary results of the subsequent offering
Reading Time: 7 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT